share_log

Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024

Benzinga ·  Oct 28, 2024 20:13
Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment